Ori Shalem joined Pluri in 2012 and currently serves as Vice President of Operations and Manufacturing. Prior to that Mr. Shalem served as Site Manager, Director of Operations, Director of Engineering, Maintenance Engineering Team leader and Projects & Validation Engineer at Pluri. Prior to joining Pluri Mr. Shalem held the position System & Equipment Validation Engineer at Protalix Biotherapiutics. Mr. Shalem holds MSc in Systems Engineering and a B.S.c in Biotechnology Engineering, both from Ort Braude College.

Efrat Kaduri,  now Chief Business Development Officer – Pharma, was appointed Vice President Business Development in February 2022, after serving as Director of Business Development and Marketing since October 2019 and, prior to that, as Director of Business, Investor and Public Relations since 2014. Before Joining Pluri, Mrs. Kaduri worked as a strategic advisor and spokesperson for several business entities including technological incubators, medical and agrotech startups. Previous positions also included Elron Electronic Industries (TASE: ELRN), the technology investment arm of IDB group. Mrs. Kaduri holds a Master of Business Administration (MBA) from the Haifa University and a BA in Psychology and Communications from the City University of New York.

Nofar Glaich-Dabach leads Pluri’s organizational culture and is responsible for organizational development, talent acquisition, and employee well-being. She joined the company’s Human Resources team in 2011 as an HR Specialist and steadily advanced through a range of leadership roles, including Director of HR. In 2025, she was appointed Vice President of Human Resources. With over a decade of experience in the field, Nofar brings deep expertise in human capital strategy and an intimate understanding of Pluri’s business and people. She holds both a master’s degree in Organizational Consulting and Human Resource Management and a bachelor’s degree in Sociology and Human Resources from the University of Haifa. She is also certified in the Myers-Briggs Type Indicator (MBTI) by CPP and the Israeli Center for MBTI.

Nimrod Bar Zvi joined Pluri as chief commercial officer in 2022 to lead global commercialization of the company’s cell-based technology Platform. Mr. Bar Zvi brings extensive senior leadership experience in the global pharmaceutical markets and active ingredients, with over 15 years in executives roles building B2B strategies, CDMO, API & Pharma sales. Prior to joining Pluri, Nimrod was the CEO of a UK CDMO inhalation company, Pharmaserve NW and led the transformation to new green propellants in devices used to deliver respiratory drugs. Previously, Mr. Bar Zvi held various supply chain and commercial executive roles for Teva Pharmaceuticals and was responsible for developing Teva API growth strategy and entering new markets and businesses worldwide. Prior to that he served as Head of their North America, LATAM and China API commercial offices responsible for over 300m$ annual sales operations globally. Previously, he led Teva API Commercial operations in Europe and execution of strategic acquisitions for the region including establishment of new offices in Russia and prior to that he managed new established sales forces for Teva International Group in the Far-East markets with representation in over 15 Countries including first offices in China Mainland.

Mr. Yaky Yanay was appointed as CEO from June 2019 after serving as President from February 2014.  Mr. Yanay served in variety of executive positions in Pluri since 2006 including Co-CEO, Chief Financial Officer, Chief Operating Officer and Executive Vice President. Mr. Yanay is the former Co-Chairman and current board member of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s life science and high-tech industries. Mr. Yanay founded over the years several activities and organizations to promote and support the Israeli life science industry. Before joining Pluri, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd. a public, machine vision, high-tech company. Prior to that Mr. Yanay served as manager at Ernst & Young Israel. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.

Liat Zalts is the Chief Financial Officer and Treasurer of Pluri where she is responsible for managing the financial & corporate strategy. Prior to her appointment as CFO, Mrs. Zalts served as Pluri’s Director of Finance. Mrs. Zalts joined Pluri from Matics Manufacturing Analytics Ltd., a SaaS, high-tech company based in Israel, where she served as CFO. Before Matics, Mrs. Zalts worked at Ernst & Young Israel (EY) and served as a manager of audit groups relating to public and private companies in the high-tech department. Mrs. Zalts holds a bachelor’s degree in economics and business management from Haifa University, a degree in accounting from Bar Ilan University and is a Certified Public Accountant in Israel.

Lior Raviv joined Pluri in 2011 and currently serves as Chief Technology Officer. Prior to that Mr. Raviv served as VP Operations & Development, Process Development Engineer, Projects Manager and Product development Team leader at Pluri. Prior to joining Pluri and during the years 2010-2011, Mr. Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries. Mr. Raviv holds a M.Med.Sec in pharmacology from the Ben Gurion University and a B.S.c, in Biotechnology engineering from the Ben Gurion University.